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Abstract
Cyclooxygenase (COX)-2, the inducible isoform of cyclooxygenase, plays a role in the process of uterine decidualization and
blastocyst attachment. On the other hand, overexpression of COX-2 is involved in the proliferation of the endometrial tissue
during endometriosis. Deregulation of the renin-angiotensin-system plays a role in the pathophysiology of endometriosis
and pre-eclampsia. Angiotensin II increases intracellular Ca
2+ concentration by targeting phospholypase C-gamma in
endometrial stromal cells (ESC). A key element of the cellular response to Ca
2+ signals is the activity of the Ca
2+- and
calmodulin-dependent phosphatase calcineurin. Our first aim was to study whether angiotensin II stimulated Cox-2 gene
expression in rat ESC and to analyze whether calcineurin activity was involved. In cells isolated from non-pregnant uteri,
COX-2 expression -both mRNA and protein- was induced by co-stimulation with phorbol ester and calcium ionophore (PIo),
as well as by angiotensin II. Pretreatment with the calcineurin inhibitor cyclosporin A inhibited this induction. We further
analyzed the role of the calcineurin/NFAT signaling pathway in the induction of Cox-2 gene expression in non-pregnant rat
ESC. Cyclosporin A abolished NFATc1 dephosphorylation and translocation to the nucleus. Cyclosporin A also inhibited the
transcriptional activity driven by the Cox-2 promoter. Exogenous expression of the peptide VIVIT -specific inhibitor of
calcineurin/NFAT binding- blocked the activation of Cox-2 promoter and the up-regulation of COX-2 protein in these cells.
Finally we analyzed Cox-2 gene expression in ESC of early-pregnant rats. COX-2 expression -both mRNA and protein- was
induced by stimulation with PIo as well as by angiotensin II. This induction appears to be calcineurin independent, since it
was not abrogated by cyclosporin A. In conclusion, angiotensin II induced Cox-2 gene expression by activating the
calcineurin/NFAT signaling pathway in endometrial stromal cells of non-pregnant but not of early-pregnant rats. These
results might be related to differential roles that COX-2 plays in the endometrium.
Citation: Abraham F, Sacerdoti F, De Leo ´n R, Gentile T, Canellada A (2012) Angiotensin II Activates the Calcineurin/NFAT Signaling Pathway and Induces
Cyclooxygenase-2 Expression in Rat Endometrial Stromal Cells. PLoS ONE 7(5): e37750. doi:10.1371/journal.pone.0037750
Editor: Shree Ram Singh, National Cancer Institute, United States of America
Received December 29, 2011; Accepted April 24, 2012; Published May 25, 2012
Copyright:  2012 Abraham et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Consejo Nacional de Investigaciones Cientı ´ficas y Te ´cnicas (CONICET; www. conicet.gov.ar) (PIP 2009-
2011) and Universidad de Buenos Aires (UBACyT-B406) and (UBACyT-B118; www.uba.ar). The funders had no role in the study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: acanell@ffyb.uba.ar
¤ Current address: Laboratorio de Fisiopatogenia, Departamento de Fisiologı ´a, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
Introduction
It has been demonstrated that prostaglandins are involved in the
process of uterine decidualization and blastocyst attachment to the
uterus. PGE2 and PGI2 are thought to be implicated in the
increase of vascular permeability during implantation and are
known to be essential factors for the decidualization process [1,2].
COX-2 is the inducible isoform of cyclooxygenase, the rate-
limiting enzyme that converts arachidonic acid into prostaglan-
dins. The COX-1 isoform is constitutively expressed in most
tissues [3,4] whereas the expression of COX-2 can be induced by
several inflammatory stimuli, including cytokines and growth
factors. The aberrant expression of COX-2 in the uterine tissue
surrounding the blastocyst contributes to the implantation failure
in LIF (2/2) mice [5]. COX-2 deficient females are infertile,
having abnormalities in ovulation, fertilization, implantation or
decidualization [6]. Moreover, overexpression of COX-2 is
involved in the proliferation of the endometrial tissue during
endometriosis [7]. In spite of this evidence about the relevance of
the presence of COX 2 in endometrial tissue, the molecular
pathways involved in the regulation of this expression remains
unclear.
The expression of COX-2 has been linked to activation of the
renin-angiotensin-system (RAS) in cells of the kidney [8]. The
RAS is an activation cascade that plays a key role in the regulation
of blood pressure and the hydro-electrolytic balance. Renin
enzymatically cleaves angiotensin, to produce angiotensin I which
in turn is cleaved by angiotensin-converting enzyme (ACE) to
render the biologically active effector molecule angiotensin II (Ang
II). Ang II acts by binding to types angiotensin (AT)1, AT2, and
non-classical- non-AT1/AT2 receptors. During pregnancy, plas-
ma renin concentration and activity as well as Ang II levels are
increased [9]. It has been reported that members of the RAS and
their receptors play a role in placentation by stimulation of
extravillous trophoblast (EVT) invasion [3]. Moreover there is
growing evidence indicating that deregulation of both tissue and
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eclampsia [9,10]. In addition, ACE gene polymorphisms were
associated with endometriosis development [11].
It has been reported that Ang II increases intracellular Ca
2+
concentration [Ca
2+
i] by interaction with AT1 receptor in
trophoblast and in endometrial stromal cells (ESC) [12,13].
Calcium signaling plays an important role during implantation.
The integrin trafficking induced by the ligation of Erb receptors in
uterine epithelial and embryonic trophoblast cells is dependent on
calcium signaling [14]. Integrin ligation by extracellular matrix
fibronectin promotes trophoblast adhesion through the elevation
of [Ca
2+
i], by targeting phospholypase C-gamma (PLCc) during
mouse blastocyst implantation [15].
A key element of the cellular response to Ca
2+ signals is the
activity of the Ca
2+- and calmodulin-dependent phosphatase
calcineurin (CN) [16–18]. The main mechanism of action of this
phosphatase characterized so far is the regulation of nuclear factor
of activated T cells (NFAT) family of transcription factors. The
CN- mediated dephosphorylation promotes translocation of
NFAT proteins into the nucleus, where they bind specific elements
within target gene promoters, in many cases through association
with other transcription factors (reviewed in [19,20]). The
pharmacological action of immunosuppressive drugs such as
cyclosporin A (CsA) and FK506 is based on their inhibition of
CN in immune effector cells [21].
It has been reported that stimuli inducing a rise in the
intracellular calcium concentration are involved in CN/NFAT-
mediated induction of COX-2 expression in several cell types [22–
26] [22–26]. In addition, angiotensin II, acting at the AT1
receptor in trophoblast cells, inhibits EVT invasion, via the
calcium-activated CN/NFAT signaling pathway [12].
Ang II was related to both, inhibition [27,28] and induction
[29,30] of COX-2 expression in cells of the kidney. However,
whether the RAS has a role in the regulation of gene transcription
and COX-2 expression in ESC is not known.
In the present study we have investigated the regulation of Cox-2
gene expression in endometrial stromal cells. We show that Ang II
activates the CN/NFAT signaling pathway in primary cultures of
rat ESC, inducing the expression of COX-2 mRNA and protein.
Results
COX-2 mRNA and protein expression is transcriptionally
induced by CN- dependent calcium signaling in primary
ESC isolated from non-pregnant rats
To analyze the regulation of COX-2 expression we isolated
ESC from uteri of non-pregnant rats. The isolated cells were
cultured during 96 h (until reaching confluence). Contamination
of the cultures with epithelial cells was analyzed by assessing
expression of vimentin and cytokeratin, by immunocytochemistry.
It was found that isolated cells expressed the mesothelial marker
vimentin. No cytokeratin-positive cells were detected in any
culture (data not shown). The expression of COX-2 was then
investigated in primary cultures of the isolated ESC. Cells were
cultured in the presence of PMA (20 ng/ml) plus the Ca
2+
ionophore A23187 (Io, 1 mM) (PIo), a conventional pharmacolog-
ical means of elevating [Ca
2+i]. Semi-quantitative RT-PCR
revealed a pronounced increase in the expression of Cox-2 mRNA
in primary ESC after treatment with PIo for 4 h; Cox-2 mRNA
was undetected in non-stimulated control cells and no variation
was observed in the expression of the housekeeping gene b-actin in
response to the stimuli (Fig. 1 A). Moreover, it was found that the
accumulation of Cox-2 mRNA was completely inhibited by pre-
treatment of cells with the transcriptional inhibitor actinomycin D
(AcD, 10 mg/ml, Fig. 1 A, lanes 5 and 6). Pre-exposure of primary
ESC cultures to the CN inhibitor CsA (200 ng/ml) potently
inhibited the accumulation of Cox-2 mRNA induced by the PIo
calcium stimulus (Fig. 1 A, lanes 3 and 4). The PIo-induced up-
regulation of Cox-2 mRNA expression was paralleled by an
increase in the production of COX-2 protein. Immunoblotting
assays of whole cell extracts of ESC employing a specific antibody
revealed that COX-2 protein was significantly increased in whole
extracts from cells treated for 8 h with PIo, compared to levels
found in extracts from unstimulated cells (Fig. 1 B, lanes 1 and 2)
and was detectable after stimulation for at least 18 h (data not
shown). As shown for Cox-2 mRNA, CsA pre-treatment reduced
PIo-induced COX-2 protein synthesis (Fig. 1 B, lanes 3 and 4).
Results suggest that PIo stimulation includes a dominant calcium-
dependent signaling component which acts via CN.
Figure 1. Calcium-induced expression of COX-2 was dependent
on calcineurin activity in primary ESC of non-pregnant rats.
Primary ESC were isolated from uteri of non-pregnant rats and cultured
during 96 h. (A) Cox-2 mRNA was amplified from total RNA by semi-
quantitative RT-PCR. The transcript of b-actin was used as internal
control. Primary cells were pretreated for 1 h with vehicle (lanes 1–2),
200 ng/ml of CsA (lanes 3–4), or 10 mg/ml of actinomycin D (AcD, lanes
5–6), and then exposed to PIo (a combination of 20 ng/ml of PMA plus
1 mM calcium ionophore Io, for 4 h (lanes 2, 4, 6), or left untreated (lanes
1, 3, 5). (B) Immunoblots of whole extracts obtained from ESC showing
endogenous protein expression of COX-2 and b-actin as a loading
control. Cells were pretreated as before for 1 h with vehicle (lanes 1–2)
or CsA (lanes 3–4) and then exposed to PIo, for 8 h (lanes 2–4). (A and
B). Right panels bar plots show the densitometric data analysis of the
results shown in the left panels A and B. The COX-2/b-actin ratio was
calculated and plotted against the values obtained with the control,
non-stimulated rat ESC, which were assigned a value of 1 (ns). The
values plotted are the means 6 SD of the fold induction values
obtained from three independent experiments. Open bars, cells pre-
treated with vehicle; closed black bars, cells pre-treated with CsA;
closed gray bars, cells pre-treated with AcD. *** P,0.001; ** P,0.01
(ANOVA).
doi:10.1371/journal.pone.0037750.g001
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expression in primary ESC isolated from non- pregnant
rats
ESC isolated from non-pregnant rat uteri were cultured in the
presence of Ang II. Employing semi-quantitative RT-PCR, it was
found that Ang II stimulation (500 nM) during 4 h induced Cox-2
mRNA expression in primary ESC isolated from non-pregnant
rats (Fig. 2 A, lanes 1 and 2). Inhibition of CN by pre-treatment
with CsA, significantly inhibited the synthesis of Cox-2 mRNA in
ESC (Fig. 2 A, lanes 3 and 4).
The expression of COX-2 protein was then examined in whole
extracts of ESC by western blot. Likewise PIo, Ang II stimulation
during 8 h upregulated COX-2 protein levels in ESC isolated
from non-pregnant rats (Fig. 2 B, lanes 1 and 2). Pre-treatment of
ESC with CsA, diminished significantly the COX-2 protein
expression (Fig. 2 B, lanes 3 and 4).
NFAT expression and Ca
2+ activation of the CN/NFAT
pathway in ESC
The pharmacological stimulation of ESC isolated from non-
pregnant rats with agents that induce a rise in the cytoplasmic
calcium concentration, induced an increase of mRNA and protein
expression of COX-2 and this effect was significantly reduced
when cells were pretreated with CsA. In order to determine
whether the NFAT transcription factor is involved in the PIo and/
or Ang II stimulation of COX-2 expression, the activation of the
CN/NFAT pathway in the cells was analyzed.
The expression, phosphorylation status and subcellular locali-
zation of NFATc1, in PIo and Ang II stimulated ESC was
evaluated. Total extracts from non-stimulated and stimulated ESC
were analyzed by immunoblot with a specific antibody against
NFATc1. As shown in Fig. 3 A, in cells pre-treated with CsA for
1 h, the inhibition of NFAT-protein dephosphorylation was
evident in the retardation of the protein bands recognized by
the antibody (Fig. 3 A lanes 2, 4 and 6). It is noteworthy that the
mobility of NFAT protein was very similar in non-stimulated and
stimulated cells (Fig. 3 A lanes 1, 3 and 5). Nevertheless
densitometric analysis revealed that stimuli induced dephosphor-
ylation of NFAT, as resulted from compared dephosphorylated/
total NFAT ratio between stimulated and non stimulated cells
(Fig. 3 A, open bars). These data were confirmed by immunoflu-
orescence. NFATc1 nuclear immunostaining was mainly observed
in PIo or Ang II-stimulated cells (Fig. 3 B). Nuclear localization of
NFATc1 was evident after 30 min of PIo as well as Ang II
exposure. In cells pretreated with CsA, staining of the nucleus
diminished and NFATc1 immunoreactivity was mainly in the
cytoplasm of the cells.
The CN/NFAT signaling pathway is required for calcium-
dependent activation of Cox-2 gene expression in ESC
isolated from non-pregnant rats
Results demonstrated that CN is involved in induction of COX-
2 expression in ESC isolated from non-pregnant rats. Further-
more, it was demonstrated that the NFATc1 is dephosphorylated
and it is mainly located in the nucleus of PIo and Ang II-
stimulated ESC.
To evaluate the participation of NFATc1 in the calcium-
induced COX-2 gene expression in ESC isolated from non-
pregnant rats, we first studied whether calcium signals activate
transcription of the human Cox-2 promoter in these cells. ESC
were transfected with luciferase reporter constructs; these
constructs were driven by versions of the human Cox-2 promoter
harboring nested deletions in the region spanning between
21900 bp to +2 bp from the TATA box (Fig. 4 A and [23]).
Constructs containing the 274 bp upstream of the TATA box
(21900/+2, 2431/+2, and 2274/+2) supported a PIo -induced
luciferase activities that was 2–3 fold greater than that observed in
non-stimulated cells (Fig. 4 A). In contrast, the construct
containing only the proximal 150 bp promoter region (2150/
+2) did not support increased luciferase activity above non-
stimulated levels. The latter results are in line with reports
indicating that two NFAT binding sites located between base pairs
2274 and 2150 of the human Cox-2 promoter are required for
induction via the calcium/CN pathway [22,23,26]. PIo and Ang
II-dependent activation of the p2–274 Cox-2 luciferase reporter
construct was inhibited by pre-treatment of cells with CsA (Fig. 4
B).
We confirmed that NFAT transcription factors participate in
the regulation of the Cox-2 promoter in ESC by inhibiting
endogenous NFAT signaling with a GFP fusion protein bearing
Figure 2. Ang II induced COX-2 expression in primary ESC of
non-pregnant rats. Expression was abrogated by CN inhibition.
(A) Cox-2 mRNA was amplified from total RNA purified from primary
cultures of ESC, by semi-quantitative RT-PCR. The transcript of the b-
actin gene was used as internal control. Cells were pretreated for 1 h
with vehicle (lanes 1 and 2), or 200 ng/ml of CsA (lanes 3 and 4), and
then exposed to 500 nM of Ang II for 4 h (lanes 2 and 4) or left
unexposed (lanes 1 and 3). (B) Immunoblots of whole extracts of
primary cultured ESC isolated from uteri of non-pregnant rats showing
endogenous protein expression of COX-2 and b-actin as a loading
control. Primary cultures of the cells were pretreated as before for 1 h
with vehicle (lanes 1 and 2), or CsA (lanes 3 and 4), and then exposed to
500 nM Ang II (lanes 2 and 4), or left untreated (lanes 1 and 3) for 8 h. (A
and B) Right panel bar plots show the densitometric data analysis of the
results shown in the left panels A and B. The COX-2/b-actin ratio was
calculated and plotted against the values obtained with the control,
non-stimulated rat ESC, which were assigned a value of 1 (ns). The
values plotted are the means 6 SD of the fold induction values
obtained from three independent experiments performed. Open bars,
cells pre-treated with vehicle; closed black bars, cells pre-treated with
CsA *** P,0.001; ** P,0.01 (ANOVA).
doi:10.1371/journal.pone.0037750.g002
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inhibits the CN/NFAT pathway by blocking the binding of
calcineurin to NFAT proteins, thereby preventing NFAT de-
phosphorylation [31]. Expression of GFP-VIVIT effectively
inhibited the PIo as well as Ang -induced activity of the p2–274
Cox-2 luciferase reporter construct (Fig. 4 C), whereas GFP alone
had no effect.
To further determine the role of NFAT in the Ca
2+- induced
COX-2 expression we tested whether COX-2 protein expression
in ESC could also be inhibited by the selective peptide inhibitor of
NFAT, VIVIT. The plasmids encoding GFP and the fusion
protein GFP-VIVIT were introduced in the ESC. The day after
transfection, cells were stimulated with PIo. COX-2 production
was analyzed by intracellular staining of COX-2 which permitted
direct comparison of COX-2 production by transfected (GFP-
positive) and nontransfected (GFP-negative) cells at a single cell
level in the same sample. Data analysis revealed that in GFP-N1
transfected cells, PIo induced an increase in the number of COX-2
positive, GFP expressing cells (Fig. 5 A, upper right quadrants in
upper panels). In contrast, this increase was not observed in GFP-
VIVIT transfected cells (Fig. 5 A, upper right quadrants in lower
panels). The inhibitory effect of GFP-VIVIT on COX-2
production in this cell population was reflected in the decreased
number of COX-2- producing cells (% positive) and in the mean
fluorescence intensity (MFI) of these cells. The product of these 2
numbers (% positive6MFI) is a measure of total COX-2
production by the GFP or GFP-VIVIT–expressing cells (Fig. 5
B and [32]) in non-stimulated and PIo-stimulated cells. The
percentage of inhibition by VIVIT of the PIo-induced COX-2
Figure 3. NFAT dephosphorylation and nuclear localization
was abrogated by CN inhibition in primary rat ESC. (A)
Immunoblots of whole extracts of primary cultured ESC isolated from
uteri of non-pregnant rats showing endogenous expression of NFATc1
and b-actin as loading control. Primary cultures of cells isolated from
uteri of non-pregnant rats were pretreated for 1 h with vehicle (lanes
1,3, 5) or 200 ng/ml of CsA (2, 4, 6), and then exposed for 2 h to PIo
(lanes 3 and 4); 500 nM of Ang II (lanes 5 and 6), or were left
unstimulated (ns, lanes 1 and 2). The position of phosphorylated NFAT
(P-NFATc1) and dephosphorylated NFATc1 (NFATc1) is indicated. Right
panel bar plot shows the densitometric data analysis of the results
shown in the left panel. The NFAT/b-actin ratio was calculated and then
the NFATc1/(NFATc1+NFATc1-P) ratio was plotted. The values are the
means 6 SD obtained from three independent experiments performed.
Open bars, cells pre-treated with vehicle; closed black bars, cells pre-
treated with CsA ** P,0.01; * P,0.05 (ANOVA). (B) Immunofluores-
cence analysis of endogenous NFAT protein with anti-NFATc1 antibody
(c–l) or nonimmune Ab (a and b) as control of unspecific staining.
Primary cultures of cells isolated from non-pregnant rats were
pretreated for 1 h as before with vehicle (c–h) or CsA (i–l), and then
exposed 2 h to PIo (e–f, i–j); 500 nM of Ang II (Ang, g–h, k–l), or were
left unstimulated (ns, c–d). (a, c, e, g, i, k): FITC staining of the cells. (b, d,
f, h, j, l): nuclei staining with DAPI. Magnification 2006. Shown is a
representative experiment out of three performed.
doi:10.1371/journal.pone.0037750.g003
Figure 4. Inhibition of CN and endogenous CN-NFAT binding
blocked Cox-2 gene promoter activation in primary ESC. (A) ESC
isolated from uteri of non-pregnant rats were transiently transfected
with a series of luciferase reporter plasmids containing regions of the
human Cox-2 promoter starting from 21900 down to 2150 upstream
of the transcription initiation site. The schematic representation of the
proximal 1900 bp region of the human Cox-2 gene promoter, showing
the positions of putative transcription factor response elements [22] is
embedded. Cell cultures were co-transfected with Renilla plasmids to
normalize for transfection efficiency. Transfected cells were treated for
4 h with vehicle (ns, open bars) or PIo (solid bars), and the luciferase
activity determined in cell lysates. Transcriptional activity is expressed
as the fold increase in luciferase activity above baseline levels from
transfected, nonstimulated control cells. (B) ESC transfected with the
2274 Cox-2 luciferase reporter construct were pretreated for 1 h with
vehicle (open bars) or 200 ng/ml of CsA (solid bars) and treated for 4 h
with PIo or 500 nM of Ang II as indicated. Data are presented as in A. (C)
Primary stromal cells isolated from uteri of non-pregnant rats were
transfected with 800 ng of expression constructs encoding either
pEGFP-VIVIT (solid bars) or pEGFP-N1 as control (open bars). Transfected
cells were stimulated as before for 4 h with PIo, Ang II, or left untreated
(ns), and the luciferase activity determined in cell lysates. Data are
presented as in A. (A–C) Results shown are from a representative
experiment of three performed, and values are the means 6SD of
triplicate determinations. *** P,0.001; ** P,0.01 (ANOVA).
doi:10.1371/journal.pone.0037750.g004
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production on NFAT.
Induction of COX-2 mRNA and protein is not dependent
on CN activity in primary ESC isolated from pregnant rats
The expression of COX-2 was then investigated in primary
cultures of ESC isolated from pregnant rats. Similar to a previous
report [33], semi-quantitative RT-PCR analysis and immunoblot
assays revealed that COX-2 mRNA and protein expression in
ESC increases significantly on days 4.5 and 10.5 of early
pregnancy compared to the transcript levels found in cells isolated
from non-pregnant rats (data not shown). Semi-quantitative RT-
PCR analysis showed that Cox-2 mRNA was further upregulated
by PIo (Fig. 6 A) and by Ang II stimulation during 4 h (Fig. 6 C) in
ESC isolated at 4.5 days of early pregnancy. Pre-treatment of cells
with CsA did not affect the Cox-2 mRNA accumulation (Fig. 6 A
and C, lanes 3 and 4). No variation was observed in the expression
of the housekeeping gene b-actin in response to the stimuli or the
inhibitor. Consistent with the results on mRNA transcription,
induction of COX-2 protein in primary ESC isolated at 4.5 days
of pregnancy, was not affected by CsA-treatment of the cells before
PIo and Ang II stimulation during 8 h (Fig. 6 B and D, lanes 3 and
4). These results suggest that, unlike the non-pregnant status, a CN
independent component of stimuli is involved in the PIo and Ang
II- induced upregulation of COX-2 in ESC isolated from pregnant
rats.
Discussion
The relevance of COX-2 expression in the uterus has been
established [6]. It has been reported that COX-2 expression
during the pre-implantation period is involved in the decidualiza-
tion process, by mediating PGE2 synthesis [34]. PGE2 could also
be involved in the regression of decidua basalis, since it is
significantly increased during this period of pregnancy in the rat
uterus, with COX-2 mediating its induction [33]. It has been
reported that the increased COX-2 expression and PGE2 synthesis
can mediate aromatase expression and estradiol synthesis in
eutopic as well as in ectopic ESC of patients with endometriosis.
COX-2 in turn is stimulated by estradiol, and PGE2 itself, thus
establishing a positive feedback loop that favors continuous
formation of E2 and PGE2 in endometriosis (reviewed in [7]
and [35]). Induction of COX-2 expression was also observed in
the syncytiotrophoblast [36] as well as in endothelium and smooth
muscle in systemic vasculature [37] of preeclamptic patients, and
COX-2 expression was related to the reduced blood flow in those
patients. Furthermore, it has been established the role played by
COX-2 during carcinogenesis. Aberrant COX-2 overexpression
was consequently found in various human malignomas like breast,
prostate, bladder, pancreas, skin, lungs and gastrointestinal tract
carcinomas [38], more recently also hematological malignancies
[39]. Moreover, studies in vivo and in vitro confirmed the role of
COX-2 in the development of ovarian and cervical cancer which
were associated with an increase in angiogenesis markers [40,41].
Therefore, a detailed understanding of the signaling network
controlling COX-2 expression is necessary for better character-
Figure 5. Inhibition of endogenous CN-NFAT binding with the exogenously expressed VIVIT peptide blocked COX-2 protein
expression. (A and B) Primary stromal cells isolated from uteri of non-pregnant rats were transfected with 800 ng of expression constructs encoding
either pEGFP-VIVIT or pEGFP-N1 as control. Transfected cells were stimulated for 14 h with PIo, or left untreated (ns). Cells were permeabilized and
stained for COX-2. Detection of cells co-expressing both COX-2 and GFP protein was analyzed by two color-FACScan. (A) Density plots showing
FACScan analysis of transfected cells immunostained for COX-2 protein. The percentage of acquired cells in each quadrant is embedded. (B) Upper
panels: Histograms showing COX-2 immunostaining of gated, GFP positive- cells. Left: pGFP-N1- transfected cells; rigth: pGFP-VIVIT- transfected cells.
Closed gray histogram: non-stimulated (ns) cells; open black histogram: (PIo)- stimulated cells. The percentage of COX-2-positive cells (% positive)
and the mean fluorescence intensity (MFI) from each histogram are enclosed. Lower panel: Bar graphs showing the product of the percentage of
COX-2-positive cells and the mean fluorescence intensity, from GFP-positive cells ploted in upper panels. Open bars: cells transfected with pEGFP-N1;
dark bars: cells transfected with the pEGFP-VIVIT. (A–B) The results shown are from a representative experiment of three performed, and values are
the means 6SD of duplicate determinations. *** P,0.001; ** P,0.01 (ANOVA).
doi:10.1371/journal.pone.0037750.g005
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proper application in reproductive biology. Recently, St. Louis
and co-workers [42] have studied the expression, activity and
regulation of COX-1 and COX-2 by sex steroids at specific stages
in the pregnant, pseudo-pregnant and non-pregnant rat uterus.
However, the signal transduction pathways involved in such
regulation were not elucidated. The present study demonstrates
the calcium activated CN/NFAT dependent induction of the Cox-
2 gene expression in ESC.
We observed that the Cox-2 gene was transcriptionally induced
by phorbol ester plus a calcium ionophore (PIo) in primary
cultures of ESC. PIo is a stimulus widely used to rise intracellular
Ca
2+ concentration [Ca
2+ i] and thereby triggering intracellular
signaling pathways such as CN/NFAT. In cultures of ESC isolated
from non-pregnant animals, the COX-2 induction was abolished
by pretreatment with the CN inhibitor CsA, similar to that
observed in other cell types [22,23,26]. As in other cell types,
stimuli that only augment [Ca
2+ i] such as calcium ionophore, are
not sufficient to full induce COX2 expression (data not shown and
[22,23,26]). This is consistent with the known tendency of NFATs
to cooperate with other transcription factors, including AP1,
GATA 4, MEF/2 and C/EBP and thereby integrate diverse
signaling pathways [19,20]. Many of the factors that form
transcription complex with NFATs are regulated by PKC and
RAS/MAPK pathways that are triggered by the use of phorbol
esters such as PMA [43].
It has been reported that Angiotensin II, acting at AT1
receptors, induced COX-2 expression in thick ascending limb cells
of Henle’s loop and in glomerular mesangial cells of the kidney
[8,30]. Ang II is known to activate calcium signaling in different
cell types, including trophoblast and ESC [12,13,44,45]. In
trophoblast cells Ang II, acting at the AT1 receptor, inhibits
EVT invasion, via the calcium-activated CN/NFAT signaling
pathway [12]. In rat-uterine stromal cells Ang II induced in vitro
the PGE2-dependent activation of the decidual reaction [46]. In
line with these results, we found induction of the Cox-2 gene in
ESC stimulated with Ang II. Furthermore, in ESC isolated from
non-pregnant rat uterus this induction was dependent on CN
activity.
Regardless of the animal species, the Cox-2 promoter contain a
classical TATA box, an E-box, and binding sites for transcription
factors such as nuclear factor kB, nuclear factor-IL6/CCAAT
enhancer binding protein and cyclic AMP-response element
(CRE) -binding proteins. These sequences have been shown to
act as positive regulatory elements for the Cox-2 gene transcription
in various cell types [47–50]. PMA as well as Ang II can trigger
NF-kB, C/EBP, and AP1/CREB pathways, thus promoting Cox-2
gene transcription. [51–53]. Moreover calcium- activated CN is
known to bind members of the NFAT transcription factors,
inducing their dephosphorylation, nuclear translocation, and the
transcriptional activation of the Cox-2 gene in several cell types
[22,23,26,54]. Ang II Receptor (AT)1-dependent activation of the
CN/NFAT signaling pathways have been described in placenta
and trophoblast cells [12,55], however, whether Ang II activates
this signaling pathway in uterine stromal cells have remained
unknown so far. A previous study has revealed CN A and NFATc1
mRNA and protein expression in the uterus of pregnant mice at
terminus [56]. These authors found, by quantitative RT-PCR
analysis of whole uterine RNA, that message of CN A1 as well as
NFATc1, c2 and c4 were expressed in the mouse uterus, and these
levels were shown to increase during the course of pregnancy. In
addition, we found that NFATc1 protein is expressed in primary
cultures of ESC from non-pregnant (Fig. 5) and pregnant rats (data
not shown). Moreover, the pretreatment of cells with CsA for 1 h
inhibited NFAT-protein dephosphorylation, and its nuclear
localization in PIo or Ang II stimulated cells.
Promoter deletion experiments performed in primary cultures
of ESC isolated from uteri of non-pregnant rats, located the CN-
dependent induction of Cox-2 in the region between base pairs
2274 and 2150. This region contains two NFAT binding motifs
Figure 6. Calcium-induced COX-2 expression was not abrogat-
ed by CN inhibition in primary ESC from early pregnant rats.
ESC were isolated from uteri of pregnant rats on 4.5 day post coitus
(d.p.c). (A and C) The Cox-2 mRNA was amplified from total RNA purified
from primary cultures of the isolated cells by semi-quantitative RT-PCR.
The transcript of b-actin was used as internal control. Cells were
pretreated for 1 h with vehicle (lanes 1 and 2) or 200 ng/ml of CsA
(lanes 3 and 4), and then exposed for 4 h to PIo (A), 500 nM of Ang II (C)
(lanes 2 and 4) or left unstimulated (lanes 1 and 3). (B and D)
Immunoblots showing endogenous protein expression of COX-2 and b-
actin as a loading control. (B) Primary cultures of the isolated cells were
pretreated for 1 h as before with vehicle (lanes 1 and 2) or CsA (lane 3),
and then exposed to PIo for 8 h (lanes 2 and 3) or not (lane1). (D)
Primary cultures of the isolated cells were pretreated for 1 h with
vehicle (lanes 1 and 2) or CsA (lane 3 and 4), and then exposed to Ang II
for 8 h (lanes 2 and 4) or not (lanes1 and 3). (A–D) Lower panels bar
graphs show the densitometric data analysis of the results shown in
upper panels. The COX-2/b-actin ratio was calculated and plotted
against the values obtained with the control, vehicle-treated non-
stimulated rat ESC (ns), which were assigned a value of 1. Open bars,
cells pre-treated with vehicle; closed black bars, cells pre-treated with
CsA. Values plotted are the means 6 SD of the fold induction values
obtained from three independent experiments. *P,0.05; ** P,0.01
(ANOVA).
doi:10.1371/journal.pone.0037750.g006
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cell types treated with stimuli that increased intracellular Ca
2+
concentrations [22,23,26,54]. This region also contains an AP1-
like site adjacent to the proximal NFAT binding motif [22]. It has
been found previously that PKC activators, such as PMA, induced
COX-2 expression in ESC [57]. Those PKC activators contribute
to the activation of several transcription factors including NF-kB,
AP-1, and octamer binding factors [58]. In this work we confirmed
the CN/NFATc1- dependent activation of Cox-2 gene expression
in ESC by transient over-expression of the peptide VIVIT, a
specific inhibitor of the NFAT binding to CN, in primary ESC
isolated from non-pregnant rats, thus indicating that CN/NFAT
interaction is required for the full induction of Cox-2 gene
transcription in these cells. However whether NFAT requires
cooperation with other transcription factor such as AP-1 to full
induction of COX-2 transcription in ESC deserves further
investigation.
It has been reported that IL-8 and IL-11 are induced by the
CN/NFAT signaling pathway in prokineticin 1 receptor
(PROKR1)- and prostanoid F receptor-expressing Ishikawa
(human endometrial adenocarcinoma) cells [59–62]. In those
papers the authors have described PROK1- and Prostaglandin F2
alpha-induced cytokine expression also in first trimester decidua,
but not CN/NFAT expression and activation nor the participation
of this pathway in the transcriptional regulation of the cytokines in
this tissue. Thus, the present study is the first description of the
CN/NFAT-dependent regulation of gene expression in primary
normal ESC.
In agreement with previous studies [33,42], we found a
significant increase in COX-2 mRNA and protein expression in
primary cultures of unstimulated ESC isolated from early pregnant
rats compared to levels found in non-pregnant rats (data not
shown). In pregnant rat ESC, PIo and Ang triggered further
COX-2 induction; however, this induction was not inhibited by
CsA, strongly suggesting that CN activity is not involved. Although
it was not demonstrated in this work, the NF-kB activation in the
endometrium during early pregnancy described so far [63,64] may
account for the differential regulation of COX-2 expression in
ESC between non-pregnant and pregnant uteri. In addition it has
been reported that low levels of progesterone in early pregnancy
are associated with the activation of the NF-kB signaling pathway
and the induction of gene transcription of inflammation-related
molecules including COX-2 [65].
In conclusion, the main goal of this study was to describe for the
first time the transcriptional regulation of the Cox-2 gene by Ang II
and the calcium-activated CN/NFAT signaling pathway in
primary cultures of normal endometrial stromal cells. The
COX-2 mediated synthesis of prostaglandins is a major step in
the increased angiogenesis observed during normal pregnancies
and gynecological diseases. It was described that CN/NFAT-
activated COX-2 expression was involved in the VEGF-induced
angiogenesis in the cornea [23]. Thus, it will be of great interest to
identify the roles of the calcium/CN/NFAT pathway in the
different physiological and pathological processes in the female
reproductive tract. Targeted disruption of NFAT members should
be made in order to evaluate its role during uterine differentiation
in vivo.
Materials and Methods
Animals and protocols
Adult female and male Sprague Dawley rats (150–200 g weight)
were maintained at the Institute animals facilities in a 14 h light–
10 h darkness photoperiod, and controlled room temperature
(2164uC). All procedures were conducted under consent of the
Committee on the Ethics of animal experiments of ‘‘Instituto de
Estudios de la Inmunidad Humoral Prof. R. Margni’’ (Permission
number: 3/2011), in accordance with guidelines of EU Directive
2010/63/EU, and AADEAL (Asociacio ´n Argentina de Especia-
listas en Animales de Laboratorio) recommendations for experi-
ments involving animals. Animals were provided with a pelleted
diet and water ad libitum. Females were mated at proestrus with
male rats. The presence of the vaginal plug was considered as day
0.5 of pregnancy. Animals were killed by CO2 inhalation in the
morning of days 0 (non-pregnant) and 4.5 of pregnancy, uteri were
excised aseptically and subjected to enzyme digestion to isolate
uterine cells. Five rats were used for each time of pregnancy.
Reagents
Phorbol 12-myristate 13-acetate (PMA), the Ca
2+ ionophore
A23187 (Io), Angiotensin II (Ang II), and actinomycin D (ActD),
were all purchased from Sigma Chemical (St. Louis, MO).
Cyclosporin A (CsA) was purchased from Molecular Bio Products
(San Diego, CA).
Isolation and culture of endometrial stromal cells (ESC)
Uteri from 5 rats per group were removed and pooled. ESC-
enriched uterine cells were separated from epithelial cells by
sequential enzyme digestion as described [66]. ESC-enriched
uterine cells suspensions were resuspended in Dulbecco’s Modified
Eagle Medium (D-MEM)/Ham F-12 nutrient mixed 1:1 (Gibco-
BRL/Invitrogen) containing 10% fetal bovine serum (FBS; Gibco-
BRL/Invitrogen) supplemented with 20 mM Hepes, 100 mg/ml
streptomycin, 100 U/ml penicillin, and 2 mM L-glutamine (all
from Gibco-BRL/Invitrogen), and plated into 100 mm-diameter
culture dishes during 1 h to allow macrophages and granulocytes
to adhere to the dish. Unattached cells were recovered and re-
plated at 5610
5/1.5 ml per well in 6-well plates, and cultured at
37uC and 5% CO2 in an humidified incubator to allow ESC to
adhere to plates. After 24 h, media was replaced and cells were
cultured in complete medium with 48 h-interval changes of
culture medium to remove non-adherent cells present in the
supernatant, until ESC reached confluence (1 week). The quality
of the stromal cell preparation was assessed by immunocytochem-
ical detection of cytokeratin and vimentin, as described below.
Immunofluorescence
ESC were plated on glass coverslips and cultured in a 24 well
culture plate, as described above. To assess quality of the stromal
cell culture, cells were washed twice with cold PBS and fixed for
15 min with 4% paraformaldehyde (w/v) in PBS. Cells were
washed with PBS and permeabilized for 10 min with PBS
containing 0.25% (v/v) Triton X-100. After three washes with
PBS, fixed cells were blocked with 10% bovine serum albumin in
PBS (PBS/BSA) for 20 min. Cells were incubated for 1 h at room
temperature with either a mouse monoclonal anti-vimentin
antibody (Sigma), or a monoclonal anti-cytokeratin antibody
(Sigma). After three washes with PBS, cells were incubated for
30 min at room temperature with the secondary antibody (FITC-
labeled goat anti-mouse IgG, Molecular Probes, Eugene, OR).
Cells were mounted in a DAPI-containing mounting media
(Molecular Probes) and analyzed by fluorescence microscopy
(Axiophot, Carl Zeiss, Jena, Germany).
To determine nuclear localization of NFATc1, ESC cultured on
coverslips were deprived of FCS during 16 h. Cells were exposed
to vehicle or inhibitor (CsA, 200 ng/ml) for 1 h and then treated
with the pharmacological stimuli: PIo, a combination of 20 ng/ml
phorbol myristate acetate (PMA) and 1 mM calcium ionophore
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permeabilized and blocked as described above and then incubated
for 1 h at room temperature with a mouse monoclonal anti-
NFATc1 antibody (clone 7A6, Santa Cruz Biotechnology, Santa
Cruz, CA). After washing, cells were incubated with the secondary
antibody (FITC-labeled goat anti-mouse IgG, Santa Cruz
Biotechnology), mounted and analyzed by fluorescence microsco-
py, as described above.
Cell lysis and Immunoblot analysis
Cells were grown in 6-well plates and cultured in vitro without
FCS supplementation during 16 h before experiments. Cell were
exposed to vehicle or inhibitor (CsA, 200 ng/ml) for 1 h and then
treated with the pharmacological stimuli. After 8 h of incubation,
whole-cell extracts were obtained as previously described [67].
The protein content in the extracts was determined by the
Bradford’s method [68]. Total extracts were then boiled in
Laemmli’s buffer and 25 mg of the protein mixture were then
resolved by 10% SDS-PAGE (8% polyacrylamide for NFATc1),
under reducing conditions. Proteins were transferred to nitrocel-
lulose membranes that were then blocked overnight at 4uC in Tris-
buffered saline plus 0.1% Tween-20 (TBST) containing 5% (w/v)
skimmed milk. Membranes were probed with the following
antibodies: a goat anti-rat COX-2 polyclonal antibody, a goat
anti- rat b-actin, polyclonal antibody and a mouse anti-NFAT c1
monoclonal antibody (clone 7A6, all from Santa Cruz Biotech-
nology). Membranes were then incubated with a peroxidase-
labeled secondary antibody and bound antibodies were detected
by the ECL western blotting analysis kit (Pierce, Thermo Fisher
Scientific, Rockford, IL).
RNA Isolation, Reverse Transcription, and PCR Analysis
Cells were grown in 6-well plates and cultured in vitro without
FCS supplementation of cultured medium during 16 h before
experiments. Cultured rat ESC were exposed to inhibitors (CsA,
200 ng/ml; actinomycin D, 10 mg/ml), and the pharmacological
stimuli. Total RNA was isolated from cells with TriZol isolation
reagent (Invitrogen-Life Science, Grand Island, NY). We per-
formed electrophoresis of RNA samples in 2% agarose gels to
check for genomic DNA contamination and also for RNA
degradation. Transcripts encoding rat Cox-2 were analyzed by
semiquantitative RT-PCR. One mg of total RNA was reverse-
transcribed to cDNA. The cDNA obtained was then used for PCR
amplification with specific primers for rat Cox-2 or b-actin: Cox-2
forward primer, 59-ACTTGCTCACTTTGTTGAGTCATTC-
39; reverse primer, 59-TTTGATTAGTACTGTAGGGT-
TAATG-39; b-actin forward primer, 59-GTCGA-
CAACGGCTCCGGCA-39; reverse primer, 59-
GTCAGGTCCCGGCCAGCCA-39. PCR reactions were carried
out as previously described [26]. Negative controls in which cDNA
sample was absent from PCR reaction mixture were made.
Amplified cDNAs were separated by agarose gel electrophoresis,
and bands were visualized by ethidium bromide staining. Data
shown correspond to the number of cycles where the amount of
amplified product is proportional to the abundance of starting
material.
Plasmid Constructs and Transient Transfection Assays
The GFP-VIVIT construct encodes an N-terminal fusion of the
high affinity calcineurin-binding peptide (VIVIT) to GFP protein
[31]. The pEGFP-N1 expression vector was purchased from
Clontech Laboratories, Inc. (Mountain View, CA). The Cox-2 (p2–
1900) luc plasmid containing the human Cox-2 promoter and the
derived deletion constructs Cox-2 (p2–431) luc; Cox-2 (p2–274) luc;
and Cox-2 (p2–150) luc, [22] were kindly provided by Dr. Manuel
Fresno (Centro de Biologı ´a Molecular Severo Ochoa, Madrid,
Spain). Null Renilla was purchased from Promega (Madison, WI).
ESC were plated on 35-mm dishes at 90% confluence the day
before transfection. Cells were transfected with the FuGene HD
reagent (Roche Applied Science, Buenos Aires, Argentina) in
complete DMEM-Ham F12 medium. Two mg of plasmid DNA
were used per well. Individual transfections were made up to 2 mg
with empty vector. Transfected cells were incubated for 24 h at
37uC and 5% CO2. At the end of the transfection period, culture
medium was removed and replaced by fresh DMEM:Ham F12
plus 10% fetal bovine serum and cells were further incubated for
24 h. Cells were incubated during 16 h without FBS supplemen-
tation of culture medium and then exposed to the pharmacological
stimuli. For the luciferase reporter experiments, after 5 h
stimulation, cells were lysed according to the instructions of the
Dual Glo Luciferase assay kit (Promega), and luciferase activity
was measured in a luminometer (Victor Multilabel Plate Reader,
Perkin Elmer, Waltham, MA). All samples were tested in triplicate,
and the results were normalized to a Renilla luciferase internal
control. For COX-2 protein expression assays the stimulated cells
were harvested after 14 h and analyzed by flow cytometry, as
described below.
Flow cytometry
Expression of COX-2 protein was assessed in GFP-VIVIT as
well as in pEGFP-N1 transfected cells by flow cytometry. Briefly,
transfected cells were exposed to PIo for 14 h or left unstimulated
(ns). Cells were harvested by treatment with Trypsin/EDTA
(Gibco-BRL/Invitrogen), washed twice with cold PBS and fixed
for 10 min with 0.01% paraformaldehyde (w/v) in PBS. Cells
were washed three times with PBS and permeabilized for 15 min
with PBS containing 0.5% (v/v) saponin. After three washes with
PBS-0.1% saponin (PBS-S), fixed cells were blocked with 10%
FBS in PBS-S containing 1% sodium azide for 20 min. Cells were
washed twice with PBS-S and then cells were incubated for 1 h at
room temperature with a goat polyclonal anti-COX-2 antibody
(Santa Cruz Biotechnology). After three washes with PBS-S, cells
were incubated for 30 min at room temperature with the
secondary antibody (Alexa 633-labeled rabbit anti-goat IgG,
Molecular Probes). Cells were washed twice in PBS-S, resus-
pended in ice cold PBS-S/BSA/sodium azide, and acquired by a
Cell cytometer (Partec-Pas III, Go ¨rlitz, Germany). Data were
analyzed using the WinMDI 2.9 free software (http://facs.scripps.
edu/software.html)
Data analysis
The COX-2/b-actin ratios were calculated from the densito-
metric data analysis of the RT-PCR and immunoblotting assays.
The NFATc1/b-actin ratios were calculated from the densito-
metric data analysis of the immunoblotting assays. The values
plotted are the means 6 SD of the fold induction values obtained
from three independent experiments. Data of luciferase reporter
assays and flow cytometry are the means 6 SD of triplicate
determinations from one representative experiment of three
performed.
Differences between groups were tested for significance using
one-way analysis of variance (ANOVA), and the Student-New-
man-Keuls multiple comparison test or the Bonferroni test (Fig. 3A)
as post-test. (***) corresponds to a significance of P,0.001, (**)
corresponds to P,0.01, (*) to P,0.05 and (n.s), not significant,
corresponds to P.0.05. (Motulsky, HJ Prism 4 Statistics Guide.
Graph-Pad Software Inc., San Diego CA 2003).
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